that while the immediate early α transcript α27 accumulated to comparable levels in the two cell lines, the β and γ transcripts were present at significantly higher levels in the H-ras cells than in the untransformed NIH-3T3 cells. Since transcription of these later (β and γ) genes requires early α gene products, the drastic reduction in β and γ gene expression in NIH-3T3 cells was likely due to the inability of the α transcripts to be efficiently translated. Indeed, Western blot analysis revealed that the α27 gene product ICP27 was present at a much lower level in NIH-3T3 cells than H-ras cells, despite the presence of comparable amounts of α27 transcripts in the two cell lines. Furthermore, accumulation of ICP8 (product of U L 29) and gC (product of U L 44) was observed in H-ras but not NIH-3T3 cells. It thus appears that the α transcripts were not efficiently translated in NIH-3T3 cells, which in turn led to the lack of progression of downstream events, resulting in abortive HSV-1 infection in these cells.
The authors then proceeded to investigate the mechanism by which the translation of α genes was inhibited in NIH-3T3 cells and not in H-ras cells. A well-known antiviral strategy of cells is the phosphorylation/activation of the double-stranded RNA-activated protein kinase (PKR) by viral transcripts, which leads to phosphorylation of the translation initiation factor eIF2α and therefore blocks its function in initiation of translation of viral transcripts [12, 13] . In order to avoid this, some viruses have developed mechanisms to block PKR function. γ 1 34.5 is an example of such "viral anti-PKR activity" which induces dephosphorylation of eIF2α and therefore antagonizes PKR function. In this study, in vitro kinase assays were used to demonstrate that PKR phosphorylation is more pronounced in untransformed cells as compared with H-ras cells. This was followed by western blotting to show that phosphorylation of eIF2α is also more pronounced in untransformed NIH-3T3 cells.
A mutant version of HSV-1, G207, is currently being tested in clinical trials as an anticancer therapeutic. G207 is a derivative of another mutant called R3616, which lacks both copies of γ 1 34.5 gene and can be considered as an attenuated virus. R3616 was found to infect rastransformed, but not untransformed, cells suggesting that the Ras signalling pathway can compensate for the loss of the virus' anti-PKR mechanism. Confirming the role of PKR in this regard, mouse embryonic fibroblasts (MEFs) that were deleted for PKR gene could be infected by the mutant virus while parental MEFs remained unpermissive. As expected, the use of farnesyl transferase inhibitors caused a restoration in PKR phosphorylation, thereby promoting the resistance of H-ras cells to HSV infection.
HSV-1 therefore exploits the attenuating effect of the Ras pathway on the PKR system. Once PKR system is down regulated by overactivity of the Ras signalling pathway, the stage is set for infection of cells by oncolytic viruses. This study not only provides knowledge on the mechanism behind host-cell permissiveness to HSV-1, but also provides a news basis for application of Ras blocking agents for the treatment of HSV infections.
